erlotinib (Tarceva) and bexarotene (Targretin)
D-0453
Unknown small_molecule completed
Quick answer
erlotinib (Tarceva) and bexarotene (Targretin) for Carcinoma, Non-small-cell Lung is a Unknown program (small_molecule) at LIGAND PHARMACEUTICALS INC with 1 ClinicalTrials.gov record(s).
Program details
- Company
- LIGAND PHARMACEUTICALS INC
- Indication
- Carcinoma, Non-small-cell Lung
- Phase
- Unknown
- Modality
- small_molecule
- Status
- completed